Soleno Therapeutics, Inc.

SLNONASDAQHealthcare

$53.01

+$0.00(+0.00%)

Market Cap$2.8B

P/E Ratio—

52W High$90.3199

52W Low$29.43

Avg Volume3.4M

Open$52.99

Beta-2.22

Employees Ownership Insider Trades

Soleno Therapeutics, Inc. (SLNO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SLNO · as of Feb 25, 2026

Latest filing snapshot

182

+90+97.83%vs prior year

Soleno Therapeutics, Inc. (SLNO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

182

Change (1Y)

+90

Growth % (1Y)

+97.83%

Revenue / Employee

$1.05M

Net Income / Employee

$114.8K

Market Cap

$2.8B

SLNO Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-25	2025-12-31	182	+90	+97.83%
2025-02-28	2024-12-31	92	+59	+178.79%
2024-03-07	2023-12-31	33	+8	+32.00%
2023-03-22	2022-12-31	25	+5	+25.00%
2022-03-31	2021-12-31	20	+3	+17.65%
2021-03-03	2020-12-31	17	+5	+41.67%
2020-03-04	2019-12-31	12	+3	+33.33%
2019-03-20	2018-12-31	9	-3	-25.00%
2018-04-02	2017-12-31	12	-14	-53.85%
2017-03-15	2016-12-31	26	-3	-10.34%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

AAPG

Ascentage Pharma Group International

567$1.6B #2

MIRM

Mirum Pharmaceuticals, Inc.

334$4.7B #3

APGE

Apogee Therapeutics, Inc.

196$5.1B #4

DYN

Dyne Therapeutics, Inc.

192$2.8B #5

SLNO

Soleno Therapeutics, Inc.YOU

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SLNO peer comparison

About SLNO employees

SLNO Employees · Headcount

Soleno Therapeutics, Inc. (SLNO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Soleno Therapeutics, Inc. had 182 full-time employees globally. Full-time employees only. Global consolidated headcount.

Soleno Therapeutics, Inc. employs 182 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.05M, reflecting the company's operational efficiency.

Soleno Therapeutics, Inc.'s workforce increased by 90 (97.83%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Soleno Therapeutics, Inc.'s revenue per employee of $1.05M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

SLNO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Soleno Therapeutics, Inc. had 182 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Soleno Therapeutics, Inc. employee counthow many employees does Soleno Therapeutics, Inc. haveSLNO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-25